Molecular effects of photodynamic therapy for photoaging

Archives of Dermatology

Volumn 144, Issue 10, 2008, Pages 1296-1302

  Orringer, Jeffrey S ^a   Hammerberg, Craig ^a   Hamilton, Ted ^a   Johnson, Timothy M ^a   Kang, Sewon ^a   Sachs, Dana L ^a   Fisher, Gary ^a   Voorhees, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CYTOKERATIN 16; MESSENGER RNA; PROCOLLAGEN;

ADULT; AGED; AGING; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DERMIS; EPIDERMIS; FOREARM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PHOTOAGING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PULSED DYE LASER; QUANTITATIVE ANALYSIS; SKIN BIOPSY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BIOLOGICAL MARKERS; COLLAGEN TYPE I; COMBINED MODALITY THERAPY; EPIDERMIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-16; KI-67 ANTIGEN; LASER THERAPY, LOW-LEVEL; LASERS, DYE; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROBABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SAMPLING STUDIES; SKIN AGING; TREATMENT OUTCOME; UP-REGULATION;

EID: 54349097985     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.10.1296     Document Type: Article

References (45)

1. Hsu TS, Zelickson B, Dover J, et al. Multicenter study of the safety and efficacy of a 585 nm pulsed-dye laser for the nonablative treatment of facial rhytides. Dermatol Surg. 2005;31(1):1-9.
2. Trelles MA, Allones I, Levy J, Calderhead R, Moreno-Arias G. Combined nonablative skin rejuvenation with the 595- and 1450-nm lasers. Dermatol Surg. 2004; 30(10):1292-1298.
3. Menaker GM, Wrone D, Williams R, Moy R. Treatment of facial rhytides with a non-ablative laser: a clinical and histologic study. Dermatol Surg. 1999;25(6): 440-444.
4. Goldberg DJ, Silapunt S. Histologic evaluation of a Q-switched Nd: YAG laser in the non-ablative treatment of wrinkles. Dermatol Surg. 2001;27(8):744-746.
5. Ross EV, Sajben F, Hsia J, Barnette D, Miller C, McKinlay J. Non-ablative skin remodeling: selective dermal heating with a mid-infrared laser and contact cooling combination. Lasers Surg Med. 2000;26(2):186-195.
6. Kopera D, Smolle J, Kaddu S, Kerl H. Nonablative laser treatment of wrinkles: meeting the objective? assessment by 25 dermatologists. Br J Dermatol. 2004; 150(5):936-939.
7. Rogachefsky AS, Hussain M, Goldberg D. Atrophic and a mixed pattern of acne scars improved with a 1320-nm Nd:YAG laser. Dermatol Surg. 2003;29(9): 904-908.
8. Bjerring P, Clement M, Heickendorff L. Selective non-ablative wrinkle reduction by laser. J Cutan Laser Ther. 2000;2(1):9-15.
9. Zelickson BD, Kilmer S, Bernstein E. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med. 1999;25(3):229-236.
10. Tanzi EL, Alster T. Comparison of a 1450-nm diode laser and a 1320-nm Nd: YAG laser in the treatment of atrophic facial scars: a prospective clinical and histologic study. Dermatol Surg. 2004;30(2, pt 1):152-157.
11. Dover JS, Bhatia AC, Stewart B, Arndt KA. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol. 2005;141(10):1247-1252.
12. Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin. 2007;25(1):5-14.
13. Rojanamatin J, Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study. Dermatol Surg. 2006;32(8):991-996.
14. Touma DJ, Gilchrest BA. Topical photodynamic therapy: a new tool in cosmetic dermatology. Semin Cutan Med Surg. 2003;22(2):124-130.
15. Britton JE, Goulden V, Stables G, Stringer M, Sheehan-Dare R. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol. 2005;153(4):780-784.
16. Touma D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol. 2004;140(1):33-40.
17. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol. 2000;115(2):183-192.
18. Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol. 2004;3(1)(suppl): S36-S39.
19. Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol. 2005;4(1):35-38.
20. Orringer JS, Voorhees J, Hamilton T, et al. Dermal matrix remodeling after nonablative laser therapy. J Am Acad Dermatol. 2005;53(5):775-782.
21. Orringer JS, Kang S, Johnson T, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol. 2004;140(11):1326-1332.
22. Varani J, Dame MK, Rittie L, et al. Decreased collagen production in chronologically aged skin: roles of age-dependent alteration in fibroblast function and defective mechanical stimulation. Am J Pathol. 2006;168(6):1861-1868.
23. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology. 2002;40(1):2-11.
24. Coulombe PA, Bravo NS, Paladini RD, Nguyen D, Takahashi K. Overexpression of human keratin 16 produces a distinct skin phenotype in transgenic mouse skin. Biochem Cell Biol. 1995;73(9-10):611-618.
25. Orringer JS, Johnson TM, Kang S, et al. Effect of carbon dioxide laser resurfacing on epidermal p53 immunostaining in photodamaged skin. Arch Dermatol. 2004;140(9):1073-1077.
26. Jonason AS, Kunala S, Price G, et al. Frequent clones of p53-mutated keratinocytes in normal human skin. Proc Natl Acad Sci U S A. 1996;93(24):14025-14029.
27. de Gruijl FR. P53 mutations as a marker of skin cancer risk: comparison of UVA and UVB effects. Exp Dermatol. 2002;11(suppl 1):37-39.
28. El-Domyati MB, Attia S, Saleh F, et al. Expression of p53 in normal sun-exposed and protected skin (type IV-V) in different decades of age. Acta Derm Venereol. 2003;83(2):98-104.
29. Wang PL, Sait F, Winter G. The "wildtype" conformation of p53: epitope mapping using hybrid proteins. Oncogene. 2001;20(18):2318-2324.
30. Wilonkal NM, Brash D. Ultraviolet radiation induced signature mutations in photocarcinogenesis. J Investig Dermatol Symp Proc. 1999;4(1):6-10.
31. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol. 2003;120(2):325-331.
32. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol. 2004;151(4):776-783.
33. Pinnel SR, Murad S, Darr D. Induction of collagen synthesis by ascorbic acid: a possible mechanism. Arch Dermatol. 1987;123(12):1684-1686.
34. Riekki R, Harvima I, Jukkola A, Risteli J, Oikarinen A. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy. Exp Dermatol. 2004;13(6):364-371.
35. Kuroda K, Tajima S. HSP47 is a useful marker for skin fibroblasts in formalin-fixed, paraffin-embedded tissue specimens. J Cutan Pathol. 2004;31(3):241-246.
36. Griffiths CE, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med. 1993;329(8):530-535.
37. Kucharz EJ. Hormonal control of collagen metabolism, II. Endocrinologie. 1988; 26(4):229-237.
38. Thiele BJ, Doller A, Kahne T, Pregla R, Hetzer R, Regitz-Zagrosek V. RNA-binding proteins heterogeneous nuclear ribonucleoprotein A1, E1, and K are involved in post-transcriptional control of collagen I and III synthesis. Circ Res. 2004;95(11):1058-1066.
39. Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther. 2005;7(1):21-24.
40. Karimipour DJ, Kang S, Johnson TM, et al. Microdermabrasion: a molecular analysis following a single treatment. J Am Acad Dermatol. 2005;52(2):215-223.
41. Rittíe L, Varani J, Kang S, Voorhees JJ, Fisher GJ. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. J Invest Dermatol. 2006;126(4):732-739.
42. Kang S, Voorhees JJ. Photoaging therapy with topical tretinoin: an evidence-based analysis J Am Acad Dermatol. 1998;39(2, pt 3):S55-61.
43. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic cheilitis. J Drugs Dermatol. 2004;3(5):548-551.
44. Alexiades-Armenakas MR, Geronemus R. Laser mediated photodynamic therapy of actinic keratoses. Arch Dermatol. 2003;139(10):1313-1320.
45. Strasswimmer J, Grande D. Do pulsed lasers produce an effective photodynamic therapy response? Lasers Surg Med. 2006;38(1):22-25.